Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

L&C BIOLTD

Market Cap: ₩1.5t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

Precigen

Market Cap: US$1.6b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Oscotec

Market Cap: ₩2.0t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Starpharma Holdings

Market Cap: AU$303.2m

A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.

Rubicon Research

Market Cap: ₹157.5b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

HansBiomed

Market Cap: ₩359.4b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

ALTEOGEN

Market Cap: ₩18.2t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$5.8b

Engages in the development of drugs.

Bonesupport Holding

Market Cap: SEK 15.1b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Sernova Biotherapeutics

Market Cap: CA$65.1m

Operates as a clinical-stage biotechnology company in Canada.

Neuland Laboratories

Market Cap: ₹227.0b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Clarity Pharmaceuticals

Market Cap: AU$1.1b

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.

Akeso

Market Cap: HK$123.4b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Clene

Market Cap: US$84.3m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

3billion

Market Cap: ₩369.1b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

Newron Pharmaceuticals

Market Cap: CHF 276.6m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Guard Therapeutics International

Market Cap: SEK 21.7m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Mesoblast

Market Cap: AU$2.6b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Abeona Therapeutics

Market Cap: US$341.9m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Forum Markets

Market Cap: US$97.5m

A financial technology company, develops a blockchain-based platform focused on the acquisition, structuring, and tokenization of real-world assets worldwide.

Ocumension Therapeutics

Market Cap: HK$5.7b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

Jiangxi Fushine Pharmaceutical

Market Cap: CN¥9.9b

Engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally.

Ascentage Pharma Group International

Market Cap: HK$15.7b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$42.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Pharma Mar

Market Cap: €1.8b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

Adocia

Market Cap: €97.5m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

Clinuvel Pharmaceuticals

Market Cap: AU$477.6m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Corcept Therapeutics

Market Cap: US$5.6b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Aether Industries

Market Cap: ₹161.0b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

OSE Immunotherapeutics

Market Cap: €88.3m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Hyperion DeFi

Market Cap: US$40.7m

Operates as a digital asset treasury and ophthalmic technology company in the United States.

Verrica Pharmaceuticals

Market Cap: US$144.8m

A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.

Caliway Biopharmaceuticals

Market Cap: NT$161.9b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Senores Pharmaceuticals

Market Cap: ₹44.5b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Kuros Biosciences

Market Cap: CHF 802.3m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Genovis AB (publ.)

Market Cap: SEK 1.4b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.